* Avid Bioservices Inc CDMO.OQ reported a quarterly
adjusted
loss of 15 cents per share for the quarter ended in October,
lower than the same quarter last year, when the company reported
EPS of -2 cents. The mean expectation of five analysts for the
quarter was for a loss of 6 cents per share. Wall Street
expected results to range from -9 cents to -5 cents per share.
* Revenue fell 26.9% to $25.40 million from a year ago;
analysts
expected $33.21 million.
* Avid Bioservices Inc's reported EPS for the quarter was a
loss
of 15 cents.
* The company reported a quarterly loss of $9.51 million.
* Avid Bioservices Inc shares had fallen by 44.0% this
quarter and
lost 61.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Avid Bioservices
Inc is $16.00
This summary was machine generated from LSEG data December 8 at
05:41 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Oct. 31 2023 -0.06 -0.15 Missed
Jul. 31 2023 -0.03 -0.03 Met
Apr. 30 2023 0.00 0.00 Met
Jan. 31 2023 -0.03 0.01 Beat